• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML SKU1; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML SKU1; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94506JR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Cellulitis (1768); Foreign Body Reaction (1868)
Event Date 12/09/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The events of dental abscess draining into right cheek causing cellulitis, injection sites became hard, indurated, swollen, and granulomatous with facial disfigurement, extreme swelling, change in sensation and pins and needles, and fillers acted as foreign bodies attacked by the inflammatory processes are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Device labeling addresses the reported events as follows: precautions for use: ¿ "as a matter of general principle, implantation of medical device is associated with a risk of infection." undesirable effects: "the patient must be informed that there are potential side effects associated with implantation of this product, which may occur immediately or may be delayed.These include but are not limited to: ¿ inflammatory reactions (redness, oedema, erythema, etc.), which can occur simultaneously with itching or pain on pressure, can appear after the injection.These reactions can last for a week.¿ indurations or nodules at the injection area.¿ poor efficiency or poor filling/restoration effect.¿ cases of necroses in the glabellar region, abscesses, granuloma and immediate or delayed hypersensitivity after hyaluronic acid and/or lidocaine injections have been reported.It is therefore advisable to take these potential risks into account.".
 
Event Description
Patient, who is also an orthodontist, reported injecting theirself with 1ml of juvéderm® volbella¿ with lidocaine in the lips and 1ml of juvéderm® voluma¿ with lidocaine in the cheeks.Approximately eight months later patient developed a "dental abscess ur draining into right cheek causing cellulitis." after this "all injection sites previously done became hard, indurated, swollen and granulomatous with facial disfigurement." patient also had extreme swelling, change in sensation and pins and needles in the injected areas in the lips and cheeks.The fillers were noted to have "acted as foreign bodies attacked by the inflammatory processes." patient consulted a plastic surgeon who prescribed 5 weeks of antibiotics and anti-inflammatories, including megapen, moxibay, ciprobay, augmentin, celestamine, cataflan, flagyl, pulmison, and myprodol.Symptoms are ongoing.This is the same event and the same patient reported under mdr id# 3005113652-2017-00083 ((b)(4)).This is the first mdr submitted for the first suspect product, juvéderm® voluma¿ with lidocaine.
 
Manufacturer Narrative
Additional information: device history record summary: the documentary research in the batch file shows that no element could explain this issue: all the physicochemical and microbiological results (endotoxins, bioburden) are registered as conforming to the specifications.The extrusion force value shows an expected consistency of the product.The sterilization cycle is registered as conforming.
 
Event Description
Additional information: patient clarified that they only injected themselves with juvéderm® voluma¿ with lidocaine.Patient was injected by another physician 3 months later with juvéderm® volbella¿ with lidocaine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA WITH LIDOCAINE 1ML SKU1
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key6398705
MDR Text Key69757265
Report Number3005113652-2017-00082
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup
Report Date 03/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2016
Device Catalogue Number94506JR
Device Lot NumberVB20A50051
Was Device Available for Evaluation? No
Date Manufacturer Received03/09/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/20/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
JUVÉDERM® VOLBELLA¿ WITH LIDOCAINE
Patient Outcome(s) Required Intervention;
Patient Age45 YR
-
-